Skip to main content
. 2012 Apr 19;106(10):1591–1597. doi: 10.1038/bjc.2012.143

Figure 2.

Figure 2

Number of defective alleles (*6, *28, and *60) and grade 3 or 4 neutropenia (%) during the first cycle of irinotecan monotherapy (n=40).